Global Orthopaedic Oncology Market Growth (Status and Outlook) 2018-2023
Published On: December 2018
 
Report ID:360376
 
 
Pages: 117




Orthopaedic oncology is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.

According to this study, over the next five years the Orthopaedic Oncology market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Orthopaedic Oncology business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Orthopaedic Oncology market by product type, application, key companies and key regions.

This study considers the Orthopaedic Oncology value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 10.7.

Surgery

Chemotherapy

Targeted Therapy

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 10.8.

Hospitals

Research Laboratories

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Stryker Corporation

Amgen Inc.

Creganna Medical Group

Accentus Inc.

Canon Medical Systems

Siemens Healthineers

MD Anderson Cancer Center

F. Hoffmann-La Roche Ltd.

Novartis AG

Sanofi S.A.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Orthopaedic Oncology market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Orthopaedic Oncology market by identifying its various subsegments.

Focuses on the key global Orthopaedic Oncology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Orthopaedic Oncology with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Orthopaedic Oncology submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Orthopaedic Oncology Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Orthopaedic Oncology Market Size 2013-2023

2.1.2 Orthopaedic Oncology Market Size CAGR by Region

2.2 Orthopaedic Oncology Segment by Type

2.2.1 Surgery

2.2.2 Chemotherapy

2.2.3 Radiation Therapy

2.2.4 Targeted Therapy

2.3 Orthopaedic Oncology Market Size by Type

2.3.1 Global Orthopaedic Oncology Market Size Market Share by Type (2013-2018)

2.3.2 Global Orthopaedic Oncology Market Size Growth Rate by Type (2013-2018)

2.4 Orthopaedic Oncology Segment by Application

2.4.1 Hospitals

2.4.2 Research Laboratories

2.5 Orthopaedic Oncology Market Size by Application

2.5.1 Global Orthopaedic Oncology Market Size Market Share by Application (2013-2018)

2.5.2 Global Orthopaedic Oncology Market Size Growth Rate by Application (2013-2018)

3 Global Orthopaedic Oncology by Players

3.1 Global Orthopaedic Oncology Market Size Market Share by Players

3.1.1 Global Orthopaedic Oncology Market Size by Players (2016-2018)

3.1.2 Global Orthopaedic Oncology Market Size Market Share by Players (2016-2018)

3.2 Global Orthopaedic Oncology Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Orthopaedic Oncology by Regions

4.1 Orthopaedic Oncology Market Size by Regions

4.2 Americas Orthopaedic Oncology Market Size Growth

4.3 APAC Orthopaedic Oncology Market Size Growth

4.4 Europe Orthopaedic Oncology Market Size Growth

4.5 Middle East & Africa Orthopaedic Oncology Market Size Growth

5 Americas

5.1 Americas Orthopaedic Oncology Market Size by Countries

5.2 Americas Orthopaedic Oncology Market Size by Type

5.3 Americas Orthopaedic Oncology Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Orthopaedic Oncology Market Size by Countries

6.2 APAC Orthopaedic Oncology Market Size by Type

6.3 APAC Orthopaedic Oncology Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Orthopaedic Oncology by Countries

7.2 Europe Orthopaedic Oncology Market Size by Type

7.3 Europe Orthopaedic Oncology Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Orthopaedic Oncology by Countries

8.2 Middle East & Africa Orthopaedic Oncology Market Size by Type

8.3 Middle East & Africa Orthopaedic Oncology Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Orthopaedic Oncology Market Forecast

10.1 Global Orthopaedic Oncology Market Size Forecast (2018-2023)

10.2 Global Orthopaedic Oncology Forecast by Regions

10.2.1 Global Orthopaedic Oncology Forecast by Regions (2018-2023)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Orthopaedic Oncology Forecast by Type

10.8 Global Orthopaedic Oncology Forecast by Application

11 Key Players Analysis

11.1 Stryker Corporation

11.1.1 Company Details

11.1.2 Orthopaedic Oncology Product Offered

11.1.3 Stryker Corporation Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.1.4 Main Business Overview

11.1.5 Stryker Corporation News

11.2 Amgen Inc.

11.2.1 Company Details

11.2.2 Orthopaedic Oncology Product Offered

11.2.3 Amgen Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.2.4 Main Business Overview

11.2.5 Amgen Inc. News

11.3 Creganna Medical Group

11.3.1 Company Details

11.3.2 Orthopaedic Oncology Product Offered

11.3.3 Creganna Medical Group Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.3.4 Main Business Overview

11.3.5 Creganna Medical Group News

11.4 Accentus Inc.

11.4.1 Company Details

11.4.2 Orthopaedic Oncology Product Offered

11.4.3 Accentus Inc. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.4.4 Main Business Overview

11.4.5 Accentus Inc. News

11.5 Canon Medical Systems

11.5.1 Company Details

11.5.2 Orthopaedic Oncology Product Offered

11.5.3 Canon Medical Systems Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.5.4 Main Business Overview

11.5.5 Canon Medical Systems News

11.6 Siemens Healthineers

11.6.1 Company Details

11.6.2 Orthopaedic Oncology Product Offered

11.6.3 Siemens Healthineers Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.6.4 Main Business Overview

11.6.5 Siemens Healthineers News

11.7 MD Anderson Cancer Center

11.7.1 Company Details

11.7.2 Orthopaedic Oncology Product Offered

11.7.3 MD Anderson Cancer Center Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.7.4 Main Business Overview

11.7.5 MD Anderson Cancer Center News

11.8 F. Hoffmann-La Roche Ltd.

11.8.1 Company Details

11.8.2 Orthopaedic Oncology Product Offered

11.8.3 F. Hoffmann-La Roche Ltd. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.8.4 Main Business Overview

11.8.5 F. Hoffmann-La Roche Ltd. News

11.9 Novartis AG

11.9.1 Company Details

11.9.2 Orthopaedic Oncology Product Offered

11.9.3 Novartis AG Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.9.4 Main Business Overview

11.9.5 Novartis AG News

11.10 Sanofi S.A.

11.10.1 Company Details

11.10.2 Orthopaedic Oncology Product Offered

11.10.3 Sanofi S.A. Orthopaedic Oncology Revenue, Gross Margin and Market Share (2016-2018)

11.10.4 Main Business Overview

11.10.5 Sanofi S.A. News

12 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.